Abstract:Background and objective: Drug inhalation is generally accepted as the preferred administration method for treating respiratory diseases. To achieve effective inhaled drug delivery for an individual, it is necessary to use an interdisciplinary approach that can cope with inter-individual differences. The paper aims to present an individualised pulmonary drug deposition model based on Computational Fluid and Particle Dynamics simulations within a time frame acceptable for clinical use. Methods: We propose a model that can analyse the inhaled drug delivery efficiency based on the patient's airway geometry as well as breathing pattern, which has the potential to also serve as a tool for a sub-regional diagnosis of respiratory diseases. The particle properties and size distribution are taken for the case of drug inhalation by using nebulisers, as they are independent of the patient's breathing pattern. Finally, the inhaled drug doses that reach the deep airways of different lobe regions of the patient are studied. Results: The numerical accuracy of the proposed model is verified by comparison with experimental results. The difference in total drug deposition fractions between the simulation and experimental results is smaller than 4.44% and 1.43% for flow rates of 60 l/min and 15 l/min, respectively. A case study involving a COVID-19 patient is conducted to illustrate the potential clinical use of the model. The study analyses the drug deposition fractions in relation to the breathing pattern, aerosol size distribution, and different lobe regions. Conclusions: The entire process of the proposed model can be completed within 48 h, allowing an evaluation of the deposition of the inhaled drug in an individual patient's lung within a time frame acceptable for clinical use. Achieving a 48-hour time window for a single evaluation of patient-specific drug delivery enables the physician to monitor the patient's changing conditions and potentially adjust the drug administration accordingly. Furthermore, we show that the proposed methodology also offers a possibility to be extended to a detection approach for some respiratory diseases.

A 3D printed human upper respiratory tract model for particulate deposition profiling

An individualised 3D computational flow and particle model to predict the deposition of inhaled medicines - A case study using a nebuliser

Micron particle deposition in a tracheobronchial airway model under different breathing conditions

Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model

Numerical study on the deposition distribution and mechanism of inhaled drug particles in various regions of the realistic inhaler-airway model

Salbutamol Transport and Deposition in the Upper and Lower Airway with Different Devices in Cats: A Computational Fluid Dynamics Approach

Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery

Numerical Simulation of Inhaled Aerosol Particle Deposition Within 3d Realistic Human Upper Respiratory Tract

Rapid deposition analysis of inhaled aerosols in human airways

Study on Airflow and Inhaled Particle Deposition Within Realistic Human Upper Respiratory Tract

Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling

Visualization and Quantitative Evaluation of Aerosol Deposition Using 3D-Printed Adult Nose Cavities

Aerosol deposition and airflow dynamics in healthy and asthmatic human airways during inhalation

A Comprehensive Numerical Study on the Transport and Deposition of Nasal Sprayed Pharmaceutical Aerosols in a Nasal‐To‐Lung Respiratory Tract Model

Characterization of Pediatric Extrathoracic Aerosol Deposition with Air-Jet Dry Powder Inhalers

In Silico Investigation of Inhalation Condition Impacts on Hygroscopic Growth and Deposition of Salbutamol Sulphate in Human Airways

Coupled Discrete Phase and Eulerian Wall Film Models for Drug Deposition Efficacy Analysis in Human Respiratory Airways

Modeling micro-particle deposition in human upper respiratory tract under steady inhalation

Simulating the effect of individual upper airway anatomical features on drug deposition

Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data

Development of an Add-On Device Using 3D Printing for the Enhancement of Drug Administration Efficiency of Dry Powder Inhalers (Accuhaler)